By 2035, Canada could have the most enviable healthcare system in the world if obesity is recognized as a chronic disease, predicts Obesity Canada
EDMONTON, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- Nearly 30,000 deaths from noncommunicable diseases in Canada in 2019, were due to high body mass index (BMI), most related to diabetes, cardiovascular disease, and obesity-related cancers. There is extreme urgency for provincial and territorial health authorities to recognize obesity as a chronic disease and act, which would prevent and improve the burden of several related conditions and take the pressure off the health care system.
Approximately 500 leading obesity and hypertension experts and allied health professionals from across Canada are gathering in Banff April 3-6, to unveil groundbreaking research, explore innovative treatments, and advocate for pivotal policy changes in tackling two of the nation's most pressing health concerns.
Why It Matters:
The health risk to individuals: According to the World Obesity Atlas 2024, approximately 30% of Canadian adults are living with obesity and without changes, that number will increase to 49% by 2035, further stressing our healthcare system.
The multiplication factor of obesity: Obesity is intricately linked with various chronic diseases, including cardiovascular diseases, diabetes, certain cancers, and joint problems, placing an immense burden on individual health and healthcare systems.
Obesity can be treated effectively; we know what to do: Canada is a global leader in obesity research and clinical expertise. The Canadian Obesity Clinical Practice Guidelines are globally recognized as the gold standard and Canadian experts are highly regarded as thought leaders. There are effective evidence-based treatment and management strategies available.
Revolutionizing our healthcare system: By officially recognizing obesity as a chronic disease and investing in evidence-based strategies, Canada (provincial and territorial health ministries) has the potential to lead the world in healthcare excellence within the next decade, predicts Obesity Canada.
Event Details:
What: "Obesity and Hypertension in Canada: Science to Solutions" Conference When: April 3rd to 6th, 2024 Where: Fairmont Banff Springs Hotel, Banff, Alberta
Media Contact:
For interviews with obesity experts and people with lived experience or for media accreditation to attend the conference:
Danielle Côté Garnet Communications Tel: (613) 799-9057 Email: [email protected]
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...
Filament Health Corp. (Cboe CA: FH) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced that Chris Wagner has stepped down from his position as Director on the Company's board of directors...
Starting this week, National Alliance for Hispanic Health, Ibero American Action League Inc., University of Rochester Medical Center, and Trillium Health in Rochester, NY will host the All of Us Journey, a traveling educational exhibit that brings...
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...